Published in BMC Biotechnol on May 09, 2003
Engineering biomaterial systems to enhance viral vector gene delivery. Mol Ther (2011) 1.07
Development of adenovirus immobilization strategies for in situ gene therapy. J Gene Med (2008) 1.01
Bioluminescence imaging for assessment and normalization in transfected cell arrays. Biotechnol Bioeng (2007) 0.94
Digoxigenin modification of adenovirus to spatially control gene delivery from chitosan surfaces. J Control Release (2009) 0.81
Enhanced transduction of colonic cell lines in vitro and the inflamed colon in mice by viral vectors, derived from adeno-associated virus serotype 2, using virus-microbead conjugates bearing lectin. BMC Biotechnol (2007) 0.75
Avidin. Adv Protein Chem (1975) 10.27
Gene therapy -- promises, problems and prospects. Nature (1997) 6.02
Avidin and streptavidin. Methods Enzymol (1990) 5.47
Microarrays of cells expressing defined cDNAs. Nature (2001) 5.05
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med (2001) 4.02
Introduction to avidin-biotin technology. Methods Enzymol (1990) 1.96
Gene therapy: promises and problems. Annu Rev Genomics Hum Genet (2001) 1.82
A perspective on protein microarrays. Nat Biotechnol (2002) 1.74
An infectious transfer and expression system for genomic DNA loci in human and mouse cells. Nat Biotechnol (2001) 1.46
Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs (2000) 1.42
Arrayed adenoviral expression libraries for functional screening. Nat Biotechnol (2002) 1.26
Foreword and introduction to the book (strept)avidin-biotin system. Biomol Eng (1999) 1.05
Viruses as gene delivery vectors: application to gene function, target validation, and assay development. Cancer Gene Ther (2002) 0.98
Adenovirus-microbead conjugates possess enhanced infectivity: a new strategy for localized gene delivery. Virology (2002) 0.98
Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells. Gene Ther (2000) 0.97
Molecular engineering of streptavidin. Ann N Y Acad Sci (1996) 0.91
Adenovirus-based libraries: efficient generation of recombinant adenoviruses by positive selection with the adenovirus protease. Gene Ther (2002) 0.86
Photochemical control of the infectivity of adenoviral vectors using a novel photocleavable biotinylation reagent. Chem Biol (2002) 0.85
D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med (2008) 9.00
Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer (2009) 4.04
Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol (2006) 2.73
Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study. J Am Coll Surg (2013) 2.19
Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol (2013) 2.16
Endoscopic evaluation of the remnant stomach after gastrectomy: proposal for a new classification. Gastric Cancer (2002) 2.01
Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. Clin Cancer Res (2012) 1.74
Optimal management of gastric cancer: results from an international RAND/UCLA expert panel. Ann Surg (2014) 1.61
Treatment of early gastric cancer in the elderly patient: results of EMR and gastrectomy at a national referral center in Japan. Gastrointest Endosc (2005) 1.60
Pancreaticoduodenectomy for advanced gastric cancer. Gastric Cancer (2005) 1.53
Two distinct pathways of tumorigenesis of adenocarcinomas of the esophagogastric junction, related or unrelated to intestinal metaplasia. Pathol Int (2007) 1.50
Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. J Clin Oncol (2012) 1.38
Recurrence in early gastric cancer with lymph node metastasis. Gastric Cancer (2009) 1.33
Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol (2007) 1.33
Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections. Langenbecks Arch Surg (2012) 1.28
Assessment of rapid tests for detection of human immunodeficiency virus-specific antibodies in recently infected individuals. J Clin Microbiol (2008) 1.26
Metastatic bone cancer as a recurrence of early gastric cancer -- characteristics and possible mechanisms. World J Gastroenterol (2005) 1.24
Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples. Cancer Sci (2008) 1.23
Successful application of laparoscopic and endoscopic cooperative surgery (LECS) for a lateral-spreading mucosal gastric cancer. Gastric Cancer (2012) 1.20
Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501). Ann Surg Oncol (2006) 1.19
Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210). J Surg Oncol (2013) 1.18
Three-step esophagojejunal anastomosis with atraumatic anvil insertion technique after laparoscopic total gastrectomy. J Gastrointest Surg (2011) 1.16
Symptom evaluation of long-term postoperative outcomes after pylorus-preserving gastrectomy for early gastric cancer. Gastric Cancer (2007) 1.15
Gastric cancer surgery in the elderly without operative mortality. Surg Oncol (2004) 1.11
Follow-up of gastric cancer: a review. Gastric Cancer (2006) 1.10
TNM and Japanese staging systems for gastric cancer: how do they coexist? Gastric Cancer (2004) 1.09
Therapeutic value of lymph node dissection in advanced gastric cancer with macroscopic duodenum invasion: is the posterior pancreatic head lymph node dissection beneficial? Ann Surg Oncol (2009) 1.09
Postoperative pancreatic fistula and the risk factors of laparoscopy-assisted distal gastrectomy for early gastric cancer. Ann Surg Oncol (2011) 1.09
Prognostic significance of complications after curative surgery for gastric cancer. Ann Surg Oncol (2013) 1.07
Billroth 1 versus Roux-en-Y reconstructions: a quality-of-life survey at 5 years. Int J Clin Oncol (2007) 1.07
Clinicopathological characteristics and survival difference between gastric stump carcinoma and primary upper third gastric cancer. J Gastrointest Surg (2012) 1.07
Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002). Gastric Cancer (2009) 1.06
Long-term and surgical outcomes of laparoscopic surgery for gastric gastrointestinal stromal tumors. Surg Endosc (2014) 1.03
Gallstone formation after gastric cancer surgery. J Gastrointest Surg (2009) 1.03
Long-term outcome and survival with laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer. Surg Endosc (2010) 1.02
Early gastric cancer: concepts, diagnosis, and management. Int J Clin Oncol (2005) 1.00
Investigation of the lymphatic stream of the stomach in gastric cancer with solitary lymph node metastasis. World J Surg (2009) 0.99
Postoperative outcomes and complications after laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer. Ann Surg (2011) 0.99
Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients. Gastric Cancer (2013) 0.99
Adenovirus-microbead conjugates possess enhanced infectivity: a new strategy for localized gene delivery. Virology (2002) 0.98
Large-scale investigation into dumping syndrome after gastrectomy for gastric cancer. J Am Coll Surg (2010) 0.98
Effects of reconstruction methods on a patient's quality of life after a proximal gastrectomy: subjective symptoms evaluation using questionnaire survey. Langenbecks Arch Surg (2008) 0.96
Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer. Gastric Cancer (2014) 0.96
Decreasing complication rates with stapled esophagojejunostomy following a learning curve. Gastric Cancer (2000) 0.95
Updates on surgical management of advanced gastric cancer: new evidence and trends. Insights from the First International Course on Upper Gastrointestinal Surgery--Varese (Italy), December 2, 2011. Ann Surg Oncol (2013) 0.95
Outcome of surgical treatment for patients with locoregional recurrence of gastric cancer. Langenbecks Arch Surg (2010) 0.95
General perioperative management of gastric cancer patients at high-volume centers. Gastric Cancer (2011) 0.94
Use of an acute seroconversion panel to evaluate a third-generation enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies relative to multiple other assays. J Clin Microbiol (2006) 0.94
Therapeutic outcomes of endoscopic submucosal dissection of undifferentiated-type intramucosal gastric cancer without ulceration and preoperatively diagnosed as 20 millimetres or less in diameter. Dig Endosc (2010) 0.94
Significance of lavage cytology in advanced gastric cancer patients. World J Surg (2010) 0.94
Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A). Gastric Cancer (2013) 0.94
Potential of xanthones from tropical fruit mangosteen as anti-cancer agents: caspase-dependent apoptosis induction in vitro and in mice. Appl Biochem Biotechnol (2010) 0.93
Evaluation of an IgM/IgG sensitive enzyme immunoassay and the utility of index values for the screening of syphilis infection in a high-risk population. Sex Transm Dis (2011) 0.93
Increasing body mass index in Japanese patients with gastric cancer. Gastric Cancer (2005) 0.93
The clinical safety of performing laparoscopic gastrectomy for gastric cancer by trainees after sufficient experience in assisting. World J Surg (2013) 0.92
Prevalence and correlates of Trichomonas vaginalis among incarcerated persons assessed using a highly sensitive molecular assay. Sex Transm Dis (2010) 0.92
Primary large cell neuroendocrine carcinoma of the urinary bladder. Int J Urol (2008) 0.92
Risk factors for pancreas-related abscess after total gastrectomy. Gastric Cancer (2005) 0.91
Survival benefit of pylorus-preserving gastrectomy in early gastric cancer. J Am Coll Surg (2009) 0.89
Screening and confirmation of human immunodeficiency virus type 1 infection solely by detection of RNA. J Med Microbiol (2008) 0.88
Oncologic outcomes of laparoscopy-assisted distal gastrectomy for gastric cancer. Ann Surg Oncol (2013) 0.87
A Phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by surgery in gastric cancer patients with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1002. Jpn J Clin Oncol (2012) 0.86
Using the Neisseria gonorrhoeae multiantigen sequence-typing method to assess strain diversity and antibiotic resistance in San Francisco, California. Microb Drug Resist (2012) 0.86
Photochemical control of the infectivity of adenoviral vectors using a novel photocleavable biotinylation reagent. Chem Biol (2002) 0.85
Short-term outcomes of Roux-en-Y stapled anastomosis after distal gastrectomy for gastric adenocarcinoma. J Gastrointest Surg (2009) 0.85
Different features of complications with Billroth-I and Roux-en-Y reconstruction after laparoscopy-assisted distal gastrectomy. J Gastrointest Surg (2011) 0.85
Potentially fatal complications for elderly patients after laparoscopy-assisted distal gastrectomy. Gastric Cancer (2013) 0.84
Thoracic lymph node involvement in adenocarcinoma of the esophagogastric junction and lower esophageal squamous cell carcinoma relative to the location of the proximal end of the tumor. Ann Surg Oncol (2014) 0.83
Increased fat content and body shape have little effect on the accuracy of lymph node retrieval and blood loss in laparoscopic distal gastrectomy for gastric cancer. J Gastrointest Surg (2008) 0.83
Differential host growth regulation by the solitary endoparasitoid, Meteorus pulchricornis in two hosts of greatly differing mass. J Insect Physiol (2010) 0.82
Totally laparoscopic pylorus-preserving gastrectomy for early gastric cancer in the middle stomach: technical report and surgical outcomes. Gastric Cancer (2014) 0.82
What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panel. Surgery (2013) 0.81
Selective cleavage of allyl and propargyl ethers to alcohols catalyzed by Ti(O-i-Pr)4/MXn/Mg. Org Lett (2007) 0.81
Risk factors for para-aortic lymph node metastasis of gastric cancer from a randomized controlled trial of JCOG9501. Jpn J Clin Oncol (2007) 0.81
Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer. Gastric Cancer (2013) 0.81
Feasibility and nutritional impact of laparoscopy-assisted subtotal gastrectomy for early gastric cancer in the upper stomach. Ann Surg Oncol (2014) 0.81
Hemocompatibility of a hydrodynamic levitation centrifugal blood pump. J Artif Organs (2007) 0.80
Laparoscopy-assisted subtotal gastrectomy with very small remnant stomach: a novel surgical procedure for selected early gastric cancer in the upper stomach. Gastric Cancer (2011) 0.80
Incidence of nodal metastasis around the superior border of the pancreas based on number of metastatic perigastric nodes. Gastric Cancer (1998) 0.80
Esophagectomy for superficial esophageal cancer after non-curative endoscopic resection. J Gastroenterol (2014) 0.80
Subtotal gastrectomy with limited lymph node dissection is a feasible treatment option for patients with early gastric stump cancer. J Gastrointest Surg (2014) 0.80
Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus. Gen Thorac Cardiovasc Surg (2014) 0.79
A Phase III trial to evaluate the effect of perioperative nutrition enriched with eicosapentaenoic acid on body weight loss after total gastrectomy for T2-T4a gastric cancer. Jpn J Clin Oncol (2012) 0.79
Correlation between the length of the pyloric cuff and postoperative evaluation after pylorus-preserving gastrectomy. Gastric Cancer (2010) 0.79
Determination of the optimal cutoff percentage of residual tumors to define the pathological response rate for gastric cancer treated with preoperative therapy (JCOG1004-A). Gastric Cancer (2014) 0.78
Long-term results of hepatic resection for non-colorectal, non-neuroendocrine liver metastasis. Hepatogastroenterology (2013) 0.78
Clinical Neisseria gonorrhoeae isolates in the United States with resistance to azithromycin possess mutations in all 23S rRNA alleles and the mtrR coding region. Microb Drug Resist (2011) 0.78
A RAND/UCLA appropriateness study of the management of familial gastric cancer. Ann Surg Oncol (2012) 0.78
Significance of the inflammation-based Glasgow prognostic score for short- and long-term outcomes after curative resection of gastric cancer. J Gastrointest Surg (2012) 0.78
Meeting report: the 75th Congress of the Japanese Gastric Cancer Association. Gastric Cancer (2004) 0.77
[Reconstruction after distal gastrectomy]. Nihon Geka Gakkai Zasshi (2008) 0.77
Clinical significance of molecular detection of matrix metalloproteinase-1 in bone marrow and peripheral blood in patients with gastric cancer. Ann Surg Oncol (2011) 0.77
Assessment of sensitivity and specificity of first, second, and third generation EIA for the detection of antibodies to HIV-1 in oral fluid. J Virol Methods (2009) 0.76
Distribution of the deepest penetrating point of minute submucosal gastric cancer. Jpn J Clin Oncol (2005) 0.76
Enhanced transduction of colonic cell lines in vitro and the inflamed colon in mice by viral vectors, derived from adeno-associated virus serotype 2, using virus-microbead conjugates bearing lectin. BMC Biotechnol (2007) 0.75
[Adjuvant chemotherapy using S-1 for curatively resected gastric cancer-the nationwide clinical trial]. Gan To Kagaku Ryoho (2006) 0.75
[Advancements in endoscopic surgery for gastric and esophageal cancer]. Nihon Rinsho (2010) 0.75
[Renal artery pseudoaneurysm following retroperitoneal laparoscopic partial nephrectomy]. Hinyokika Kiyo (2009) 0.75